|

Partially Engineered T-regulatory Cell Donor Graft TRGFT-201 Clinical Trials

1 actively recruiting trial across 1 location

Also known as: Orca-T, Partially Engineered and Enriched Treg Donor Graft TRGFT-201, T-cell-Depleted Graft With Additional Infusion of Conventional T Cells and Regulatory T Cells, TRGFT 201, TRGFT-201 +2 more

Pipeline

Phase 1: 1

Top Sponsors

  • City of Hope Medical Center1

Indications

  • Myelodysplastic Syndrome1
  • Acute Myeloid Leukemia1
  • Acute Lymphoblastic Leukemia1
  • Cancer1

Duarte, California1 trial

Orca-T Following Chemotherapy and Total Marrow and Lymphoid Irradiation for the Treatment of Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia or Myelodysplastic Syndrome

City of Hope Medical Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.